BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 3128946)

  • 1. Recognition and prevention of pseudothrombocytopenia and concomitant pseudoleukocytosis.
    Lombarts AJ; de Kieviet W
    Am J Clin Pathol; 1988 May; 89(5):634-9. PubMed ID: 3128946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulant-induced pseudothrombocytopenia and pseudoleucocytosis.
    Schrezenmeier H; Müller H; Gunsilius E; Heimpel H; Seifried E
    Thromb Haemost; 1995 Mar; 73(3):506-13. PubMed ID: 7545322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EDTA-induced platelet aggregation can be avoided by a new anticoagulant also suitable for automated complete blood count.
    Lippi U; Schinella M; Nicoli M; Modena N; Lippi G
    Haematologica; 1990; 75(1):38-41. PubMed ID: 2110927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies of platelet aggregation in six cases of EDTA-dependent pseudothrombocytopenia].
    Shimasaki A; Kato T; Ozaki Y
    Rinsho Ketsueki; 1994 Jun; 35(6):529-34. PubMed ID: 8078186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition and prevention of two cases of erroneous haemocytometry counts due to platelet and white blood cell aggregation. The use of acid citrate dextrose as an auxiliary anticoagulant.
    Lombarts AJ; de Kieviet W; Franck PF; Baars JD
    Eur J Clin Chem Clin Biochem; 1992 Jul; 30(7):429-32. PubMed ID: 1525265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for EDTA-dependent deviations in platelet counts and abnormalities in platelet distribution histograms in pseudothrombocytopenia.
    Bartels PC; Schoorl M; Lombarts AJ
    Scand J Clin Lab Invest; 1997 Nov; 57(7):629-36. PubMed ID: 9397495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amikacin can be added to blood to reduce the fall in platelet count.
    Zhou X; Wu X; Deng W; Li J; Luo W
    Am J Clin Pathol; 2011 Oct; 136(4):646-52. PubMed ID: 21917689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of equine platelet function and survival in whole blood collected in acid-citrate-dextrose solution or citrate-phosphate-dextrose-adenine solution.
    Bozorgmanesh R; Sutton-Burges JW; Tablin F
    Vet Clin Pathol; 2017 Jun; 46(2):262-268. PubMed ID: 28411369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acid citrate dextrose (ACD) formula A as a new anticoagulant in the measurement of in vitro platelet aggregation.
    Pignatelli P; Pulcinelli FM; Ciatti F; Pesciotti M; Sebastiani S; Ferroni P; Gazzaniga PP
    J Clin Lab Anal; 1995; 9(2):138-40. PubMed ID: 7714666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective estimation of correct platelet counts in pseudothrombocytopenia using an alternative anticoagulant based on magnesium salt.
    Schuff-Werner P; Steiner M; Fenger S; Gross HJ; Bierlich A; Dreissiger K; Mannuß S; Siegert G; Bachem M; Kohlschein P
    Br J Haematol; 2013 Sep; 162(5):684-92. PubMed ID: 23808903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sodium citrate and acid citrate dextrose solutions on cell counts and growth factor release from equine pure-platelet rich plasma and pure-platelet rich gel.
    Giraldo CE; Álvarez ME; Carmona JU
    BMC Vet Res; 2015 Mar; 11():60. PubMed ID: 25889052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant spuriously elevated white blood cell count, a previously underestimated phenomenon in EDTA-dependent pseudothrombocytopenia.
    Xiao Y; Xu Y
    Platelets; 2015; 26(7):627-31. PubMed ID: 25275874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric analysis of platelet activation under calcium ion-chelating conditions.
    Nishioka T; Yokota M; Tsuda I; Tatsumi N
    Clin Lab Haematol; 2002 Apr; 24(2):115-9. PubMed ID: 11985558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Amikacin on Pseudothrombocytopenia.
    Bokaei PB; Grabovsky D; Shehata N; Wang C
    Acta Haematol; 2017; 137(1):27-29. PubMed ID: 27852074
    [No Abstract]   [Full Text] [Related]  

  • 15. EDTA-dependent pseudothrombocytopenia in a child.
    Akbayram S; Dogan M; Akgun C; Caksen H; Oner AF
    Clin Appl Thromb Hemost; 2011 Oct; 17(5):494-6. PubMed ID: 20530050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of theophylline in the investigation of pseudothrombocytopenia induced by edetic acid (EDTA-2K).
    Ohnuma O; Shirata Y; Miyazawa K
    J Clin Pathol; 1988 Aug; 41(8):915-7. PubMed ID: 3139717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accurate platelet counting in an insidious case of pseudothrombocytopenia.
    Lombarts AJ; Zijlstra JJ; Peters RH; Thomasson CG; Franck PF
    Clin Chem Lab Med; 1999; 37(11-12):1063-6. PubMed ID: 10726813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pseudothrombocytopenia and pseudoleukocytosis].
    Grau Segura E; Fontcuberta Boj J; Félez Brugués J
    Med Clin (Barc); 1985 May; 84(18):754. PubMed ID: 3927083
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ethylenediaminetetraacetic-acid-dependent pseudothrombocytopenia].
    Ruiz López JJ; Rosado Caracena R; Sanabria Carretero P; Goldman Tarlovsky L
    Rev Esp Anestesiol Reanim; 2009 Feb; 56(2):119-20. PubMed ID: 19334662
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pseudothrombocytopenia: incidence, causes and methods of detection].
    García Suárez J; Merino JL; Rodríguez M; Velasco A; Moreno MC
    Sangre (Barc); 1991 Jun; 36(3):197-200. PubMed ID: 1948538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.